Ajanta Pharma: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | Value Research

Ajanta Pharma: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we herein mention the schedule of Analyst/Institutional Investor Meeting with the Company.

Click here to view PDF


Other Categories